PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 54 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,592 | -77.6% | 12,813 | -67.4% | 0.00% | – |
| Q2 2023 | $176,805 | +38.1% | 39,290 | +75.0% | 0.00% | – |
| Q1 2023 | $127,994 | -59.2% | 22,455 | -56.7% | 0.00% | -100.0% |
| Q4 2022 | $313,464 | -55.1% | 51,898 | -50.9% | 0.00% | -50.0% |
| Q3 2022 | $698,000 | -40.2% | 105,601 | -52.8% | 0.00% | -50.0% |
| Q2 2022 | $1,168,000 | -6.2% | 223,836 | +24.1% | 0.00% | 0.0% |
| Q1 2022 | $1,245,000 | -64.6% | 180,412 | -36.2% | 0.00% | -50.0% |
| Q4 2021 | $3,521,000 | +1114.1% | 282,774 | +2695.3% | 0.01% | +700.0% |
| Q2 2021 | $290,000 | – | 10,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $66,362,000 | 1.23% |
| Baker Brothers Advisors | 10,123,824 | $66,918,000 | 0.44% |
| HHLR ADVISORS, LTD. | 583,333 | $3,856,000 | 0.10% |
| CAXTON ASSOCIATES LP | 85,992 | $568,000 | 0.08% |
| Virtus ETF Advisers LLC | 24,180 | $160,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 54,173 | $358,000 | 0.05% |
| DENALI ADVISORS LLC | 8,200 | $54,000 | 0.03% |
| PDT Partners, LLC | 12,641 | $84,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 2,402,595 | $15,881,153,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $244,000 | 0.01% |